- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02567240
Carbon Monoxide-Saturated Medium for Islet Isolation
January 2, 2019 updated by: Medical University of South Carolina
A Novel Approach to Harvest Islets for Autologous Islet Transplantation
The goal of this study is to determine whether harvesting islets using carbon monoxide (CO)-saturated mediums can protect islet cell from death after autologous islet transplantation in patients with chronic pancreatitis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Investigators plan to harvest human islets using carbon monoxide-saturated mediums.
Survival and function of transplanted islets will be compared with islets harvested using regular mediums.
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- GI Surgery, Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 69 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chronic pancreatitis patient selected for total pancreatectomy and islet autotransplantation.
- Age between 18-69.
Exclusion Criteria:
1. Had prior pancreatic surgeries.
Note: The study was initially designed only to enroll diabetes free patients. To increase enrollment, we extended the inclusion criteria by allowing patients who are pre-diabetic to participate the study. This revision was approved by the MUSC IRB on 11/10/2015.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Carbon monoxide-bubbled mediums
Islets will be harvested with Carbon monoxide-saturated mediums
|
Islets will be harvested with carbon monoxide bubbled mediums
|
No Intervention: Normal mediums
Islets will be harvested with regular mediums
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Area under the curve during mixed meal tolerance test
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2015
Primary Completion (Actual)
October 1, 2018
Study Completion (Actual)
December 1, 2018
Study Registration Dates
First Submitted
October 1, 2015
First Submitted That Met QC Criteria
October 1, 2015
First Posted (Estimate)
October 2, 2015
Study Record Updates
Last Update Posted (Actual)
January 4, 2019
Last Update Submitted That Met QC Criteria
January 2, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00040035
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pancreatitis
-
Changhai HospitalUnknownChronic Pancreatitis | Idiopathic Chronic PancreatitisChina
-
AbbottCompletedExocrine Pancreatic Insufficiency, Chronic PancreatitisJapan
-
Postgraduate Institute of Medical Education and...Completed
-
Dartmouth-Hitchcock Medical CenterCompleted
-
The Cleveland ClinicChiRhoClin, Inc.; The National Pancreas FoundationCompletedChronic PancreatitisUnited States
-
Massachusetts General HospitalTerminatedChronic PancreatitisUnited States
-
Winthrop University HospitalCelgene CorporationTerminatedChronic Pancreatitis
-
Kangen Pharmaceuticals, IncCompletedChronic PancreatitisUnited States, Russian Federation, Ukraine
-
Changhai HospitalEnrolling by invitationChronic PancreatitisChina
Clinical Trials on Carbon monoxide-bubbled mediums
-
MallinckrodtWithdrawnKidney TransplantationUnited States
-
UCSF Benioff Children's Hospital OaklandCapnia, Inc.CompletedSickle Cell Anemia
-
Brigham and Women's HospitalMassachusetts General Hospital; Duke University; Weill Medical College of Cornell...CompletedAcute Respiratory Distress Syndrome (ARDS)United States
-
Ashutosh LalCompletedSickle Cell AnemiaUnited States
-
Women's Hospital School Of Medicine Zhejiang UniversityJinhua Central Hospital; The Children's Hospital of Zhejiang University School... and other collaboratorsNot yet recruitingHyperbilirubinemia, Neonatal
-
Danish Headache CenterCompletedHeadache DisordersDenmark
-
Groningen Research Institute for Asthma and COPDStichting Astma Bestrijding, The NetherlandsCompletedPulmonary Disease, Chronic ObstructiveNetherlands
-
Danish Headache CenterCompletedHeadache, MigraineDenmark
-
Danish Headache CenterCompletedMigraine | HeadacheDenmark
-
Queen's UniversityThe Physicians' Services Incorporated FoundationTerminated